Published in Chest on April 10, 2009
Revefenacin in Acute Respiratory Insufficiency in COPD (RARICO) | NCT04315558
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis (2009) 1.52
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2010) 1.02
A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD. BMJ Open (2012) 0.93
Safety and tolerability of inhalational anticholinergics in COPD. Drug Healthc Patient Saf (2013) 0.82
Efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.77
Optimizing safety of COPD treatments: role of the nurse practitioner. J Multidiscip Healthc (2013) 0.77
Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2013) 0.76
Safety of ipratropium bromide. Chest (2010) 0.75
Etiology. Recent use of ipratropium bromide increased risk for cardiovascular events in chronic obstructive pulmonary disease. Ann Intern Med (2010) 0.75
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. J Gen Intern Med (2007) 6.14
Expenditures and health status among adults with back and neck problems. JAMA (2008) 6.11
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med (2015) 4.75
Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA (2003) 4.52
Global epidemiology of hepatitis B virus. J Clin Gastroenterol (2004) 4.48
Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 4.15
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med (2008) 3.60
Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm (2003) 3.34
Geographic variation in cardiovascular procedure use among Medicare fee-for-service vs Medicare Advantage beneficiaries. JAMA (2013) 3.30
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD (2005) 2.66
Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care (2008) 2.64
Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med (2007) 2.55
The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc (2004) 2.55
Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med (2013) 2.54
Design considerations, architecture, and use of the Mini-Sentinel distributed data system. Pharmacoepidemiol Drug Saf (2012) 2.41
Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care (2003) 2.33
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care (2006) 2.28
Can we reliably benchmark health technology assessment organizations? Int J Technol Assess Health Care (2012) 2.27
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer (2003) 2.20
Cost-effectiveness and population outcomes of general population screening for hepatitis C. Clin Infect Dis (2012) 2.19
Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm (2015) 2.15
Association between rising professional liability insurance premiums and primary cesarean delivery rates. Obstet Gynecol (2007) 2.13
Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med (2014) 2.08
The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report. Value Health (2003) 2.07
Statin use and lower extremity amputation risk in nonelderly diabetic patients. J Vasc Surg (2013) 2.05
Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol (2004) 2.03
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers. Appl Health Econ Health Policy (2014) 2.02
Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr (2002) 1.96
Alcohol screening scores and medication nonadherence. Ann Intern Med (2008) 1.94
Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes (2011) 1.94
A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med (2006) 1.91
The impact of computerized provider order entry on medication errors in a multispecialty group practice. J Am Med Inform Assoc (2010) 1.85
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy (2010) 1.83
Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med (2003) 1.79
Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry (2006) 1.79
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med (2003) 1.77
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? Int J Technol Assess Health Care (2010) 1.70
A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care (2007) 1.69
The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study. J Am Med Inform Assoc (2007) 1.64
A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Arch Pediatr Adolesc Med (2005) 1.63
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decision. Ann Surg (2011) 1.63
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. BMC Health Serv Res (2011) 1.62
Medicaid prior authorization and controlled-release oxycodone. Med Care (2008) 1.61
Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash) (2002) 1.59
Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol (2003) 1.57
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2014) 1.53
Regional variation in health status among chronic obstructive pulmonary disease patients. Respiration (2010) 1.52
Effects of sustained audit/feedback on self-reported health status of primary care patients. Am J Med (2004) 1.52
The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest (2014) 1.51
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol (2007) 1.50
Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest (2015) 1.49
Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis. Qual Life Res (2005) 1.49
Adult asthma disease management: an analysis of studies, approaches, outcomes, and methods. Respir Care (2009) 1.46
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Pediatr Allergy Immunol (2006) 1.45
Racial disparities in term induction of labor rates in Illinois. Med Care (2008) 1.45
An official American Thoracic Society systematic review: insurance status and disparities in lung cancer practices and outcomes. Am J Respir Crit Care Med (2010) 1.45
Lower-extremity amputation risk after charcot arthropathy and diabetic foot ulcer. Diabetes Care (2009) 1.45
The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg (2004) 1.45
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2008) 1.44
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44
The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother (2009) 1.42
Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington state. Surg Obes Relat Dis (2012) 1.42
Pretransplant lung function, respiratory failure, and mortality after stem cell transplantation. Am J Respir Crit Care Med (2005) 1.41
Vitamin d deficiency/insufficiency practice patterns in a veterans health administration long-term care population: a retrospective analysis. J Am Med Dir Assoc (2009) 1.40
Response to Wolf [corrected] and Marks. J Allergy Clin Immunol (2005) 1.39
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf (2009) 1.38
Impact of healthcare delivery system on where HMO-enrolled seniors purchase medications. Ann Pharmacother (2004) 1.38
Predictors of adherence to inhaled medications among Veterans with COPD. J Gen Intern Med (2012) 1.33
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf (2013) 1.33
Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat (2007) 1.31
The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics (2004) 1.31
A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med (2004) 1.30
Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol (2010) 1.30
Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD (2010) 1.29
Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care (2009) 1.29
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network. J Clin Epidemiol (2013) 1.28
Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience. J Manag Care Pharm (2007) 1.27
Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med (2008) 1.26
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med (2012) 1.25
Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol (2012) 1.23